Endocyte, based in West Lafayette, has been chasing a targeted drug to cure prostate cancer. Novartis deal announced Thursday
Lafayette Journal & Courier, Journal & Courier
Thu, 10/18/2018 - 6:10am
Endocyte, based in West Lafayette, has been chasing a targeted drug to cure prostate cancer. Novartis deal announced Thursday